Description
The U.S. Food and Drug Administration (FDA) is seeking a service and maintenance agreement for an Illumina NextSeq 2000 Sequencing System. The contract will include corrective/remedial repair and preventive maintenance services, with a period of performance from July 23, 2026, to July 22, 2027, and four option periods. The contractor must provide unlimited technical support and on-site service visits as needed. The FDA requires the contractor to have formally trained and certified Original Equipment Manufacturer (OEM) technicians/engineers and to use OEM replacement parts and components.
Key requirements include:
• All maintenance and repair activities shall be performed by formally trained and certified OEM technicians/engineers.
• On-site service technician(s) shall have an Enhanced Driver’s License (EDL) or appropriate identification to gain access to Government facilities.
• The contractor shall provide unlimited Corrective/Remedial and Preventive Maintenance Service(s) inclusive of shipping, labor, travel, replacement parts, components, subassemblies, components, or modules necessary for repairs.
• The contractor shall provide a completed HHS Section 508 Accessibility Conformance Checklist or an Accessibility Conformance Report (ACR) based on the Voluntary Product Accessibility Template (VPAT).